Dianthus Therapeutics EVP, CFO and CBO Ryan Savitz disposes of common shares worth $3.06 million
DNTH•Savitz exercises options and sells shares
- Dianthus Therapeutics EVP, CFO and CBO Ryan Savitz exercised stock options for 31,249 common shares at $21.77 on July 9.
- Savitz sold 31,249 common shares the same day in three blocks at weighted average prices of $100.22, $101.24, and $101.97.
- He ended the day with 0 common shares directly owned.
- He reported 68,751 stock options remaining after the transaction.
